Home Compliance Lab Pays $3.6 Million to Settle Allegedly Redundant Drug Tests ComplianceFCANews Lab Pays $3.6 Million to Settle Allegedly Redundant Drug Tests October 12, 2022 36 Share FacebookLinkedinTwitter cawee | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Second Circuit Defines “Willfulness” Standard Under Anti-Kickback Statute Compliance A Guide for Whistleblowers Under the False Claims Act Compliance Sixth Circuit Affirms Orders Compelling Relator to Seek Government Consent to Dismiss Qui Tam Pursuant to Settlement Agreement